In drug development, the success of AI depends on gathering the right data and being able to prove its authenticity when an application is subject to regulatory scrutiny. Read this Pharmaceutical Market Europe (PME) article to explore featured commentary from ICON expert Tom O’Leary on the use of AI in the pharmaceutical sector.

Download Article